FDA Inspection 900767 — CURALLUX LLC

CURALLUX LLC — FEI 3010123655

The FDA completed an inspection of CURALLUX LLC on November 7, 2014 in Doral, FL. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 17 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 7, 2014
Fiscal Year
2015
Product Type
Devices
Project Area
Compliance: Devices
Location
Doral, FL (United States)

Citations

IDCFRDescription
1471121 CFR 820.160(a)Lack of or inadequate procedures for distribution
1471221 CFR 820.184DHR - not or inadequately maintained
230221 CFR 820.20(e)Quality System Procedures
237121 CFR 820.30(a)Design control - no procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
313221 CFR 820.120Lack of or inadequate procedures for labeling
316821 CFR 820.198(a)Complaints
320621 CFR 820.50(b)Approval, inadequate purchasing data
328521 CFR 820.90(b)(2)Product rework procedures, Lack of or inadequate procedures
333121 CFR 820.181DMR - not or inadequately maintained
369621 CFR 820.100(b)Documentation
41921 CFR 820.20(b)Lack of or inadequate organizational structure
503121 CFR 1010.2(a)Lack of certification of conformance
519921 CFR 1040.10(h)(1)(iii)Legible reproductions
581121 CFR 1002.30(a)(1)Quality control procedures
581221 CFR 1002.30(a)(2)Results of tests
63021 CFR 803.17Lack of Written MDR Procedures